These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12564845)

  • 1. Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose.
    Crook MA; Goldsmith L; Ameerally P; Lumb P; Singh N; Miell J; Russell-Jones D
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):606-8. PubMed ID: 12564845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in Fijians.
    Crook MA; Miell J; Ameerally P; Lumb P; Singh N; Russell-Jones D; Goldsmith L
    Clin Chim Acta; 2003 May; 331(1-2):1-5. PubMed ID: 12691857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients.
    Gavella M; Lipovac V; Car A; Vucić M; Sokolić L; Rakos R
    Acta Diabetol; 2003 Jun; 40(2):95-100. PubMed ID: 12861408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study.
    Thomas GN; Schooling CM; McGhee SM; Ho SY; Cheung BM; Wat NM; Janus ED; Lam TH;
    Eur J Endocrinol; 2006 Oct; 155(4):623-32. PubMed ID: 16990663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
    Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose.
    Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
    Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
    Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different levels of thyroid hormones between impaired fasting glucose and impaired glucose tolerance: free T3 affects the prevalence of impaired fasting glucose and impaired glucose tolerance in opposite ways.
    Jing S; Xiaoying D; Ying X; Rui L; Mingyu G; Yuting C; Yanhua Y; Yufan W; Haiyan S; Yongde P
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):890-8. PubMed ID: 24330392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: a 15-year follow-up study.
    Guerrero-Romero F; Rodríguez-Moran M
    Eur J Intern Med; 2014 Mar; 25(3):265-9. PubMed ID: 24507408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.